Serum transglutaminase 2 activity as a potential biomarker of disease severity and response to omalizumab in chronic spontaneous urticaria
oleh: J.H. Choi, Y. Bae, K.H. Park
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2020-08-01 |
Deskripsi
No description available for this item.